Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-25 Purchase |
2025-03-27 4:40 pm |
Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer |
100,000 | $0.6925 | $69,250 | 480,123 (Direct) |
View |
| 2024-12-20 Purchase |
2024-12-26 07:49 am |
Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer |
63,075 | $1.3561 | $85,538 | 377,623 (Direct) |
View |
| 2021-12-13 Purchase |
2021-12-15 5:21 pm |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
8,000 | $11.86 | $94,880 | 268,380 (Direct) |
View |
| 2020-09-29 Purchase |
2020-09-29 8:11 pm |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
1,000 | $19 | $19,000 | 260,380 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-04 Option Award |
2025-02-05 4:32 pm |
N/A 2035-02-04 |
Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer |
175,000 | $0 | 175,000 (Direct) |
View |
| 2024-03-01 Option Award |
2024-03-04 6:05 pm |
N/A 2034-02-28 |
Prelude Therapeutics Inc | PRLD | Combs Andrew Chief Chemistry Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2023-02-07 Option Award |
2023-02-09 4:08 pm |
N/A 2033-02-06 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
135,000 | $0 | 135,000 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-04 5:08 pm |
N/A 2030-03-26 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
36,062 | $0 | 354,839 (Direct) |
View |
| 2022-03-31 Exercise |
2022-04-04 5:08 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
36,062 | $1.89 | 354,839 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 7:07 pm |
N/A 2032-02-14 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 6:07 pm |
N/A 2031-07-19 |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
95,000 | $0 | 95,000 (Direct) |
View |
Ownership |
2020-09-24 7:07 pm |
N/A N/A |
Prelude Therapeutics Inc | PRLD | Combs Andrew EVP, Head of Chemistry |
0 | $0 | 462,560 (Direct) |
View |